M&A Deal Summary |
|
|---|---|
| Date | 2015-12-14 |
| Target | PowderSize |
| Sector | Life Science |
| Buyer(s) | Capsugel Belgium NV |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1875 |
| Sector | Life Science |
| Revenue | 750M USD (2010) |
Capsugel Belgium NV is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel offers a comprehensive array of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative R&D equipment and liquid formulations as part of its Licaps Drug Delivery System.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: Pennsylvania M&A | 1 of 1 |
| Country: United States M&A | 3 of 3 |
| Year: 2015 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-14 |
Xcelience
Tampa, Florida, United States Xcelience offers a suite of services enabling clients to partner with a single CDMO for all of their global clinical outsourcing needs. Services include preformulation, micronization, analytical services, formulation development, cGMP manufacturing, small-scale commercial manufacturing, and global clinical supplies packaging and logistics. Xcelience takes pride in delivering the highest standards in science and service with an emphasis on quality, cost and speed. |
Buy | - |